HALOZYME THERAPEUTICS INC's ticker is HALO and the CUSIP is 40637H109. A total of 316 filers reported holding HALOZYME THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 0.23 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $4,344 | +5.3% | 113,720 | -0.5% | 0.01% | +11.1% |
| Q2 2023 | $4,124 | -6.7% | 114,320 | -1.2% | 0.01% | -10.0% |
| Q1 2023 | $4,418 | -33.6% | 115,681 | -1.1% | 0.01% | -37.5% |
| Q4 2022 | $6,652 | -99.9% | 116,914 | +0.2% | 0.02% | +33.3% |
| Q3 2022 | $4,616,000 | -10.6% | 116,736 | -0.5% | 0.01% | -7.7% |
| Q2 2022 | $5,162,000 | +14.1% | 117,323 | +3.4% | 0.01% | +44.4% |
| Q1 2022 | $4,526,000 | -0.6% | 113,486 | +0.2% | 0.01% | 0.0% |
| Q4 2021 | $4,555,000 | +15.8% | 113,286 | +17.1% | 0.01% | +12.5% |
| Q3 2021 | $3,935,000 | -0.6% | 96,728 | +10.9% | 0.01% | 0.0% |
| Q2 2021 | $3,960,000 | +13.7% | 87,211 | +4.4% | 0.01% | +14.3% |
| Q1 2021 | $3,483,000 | +2237.6% | 83,553 | +2287.2% | 0.01% | – |
| Q4 2020 | $149,000 | – | 3,500 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TRAN CAPITAL MANAGEMENT, L.P. | 1,084,118 | $61,686,285 | 7.80% |
| SNYDER CAPITAL MANAGEMENT L P | 3,983,814 | $226,679,017 | 5.12% |
| First Light Asset Management, LLC | 923,119 | $52,525,471 | 4.88% |
| Redwood Investments, LLC | 441,809 | $25,138,932 | 3.37% |
| BERNZOTT CAPITAL ADVISORS | 444,728 | $25,305,023 | 3.27% |
| DOHENY ASSET MANAGEMENT /CA | 46,050 | $2,620 | 3.04% |
| Crawford Lake Capital Management, LLC | 42,171 | $2,399,530 | 2.75% |
| 2Xideas AG | 416,586 | $23,703,743 | 2.51% |
| Granite Investment Partners, LLC | 902,882 | $51,373,986 | 2.14% |
| HighMark Wealth Management LLC | 41,790 | $2,377,851 | 1.79% |